Wellness Blog 
Be Fit.  Eat Right.  Think Well.

AHDH Certification for chiropractors - Nov 2011

FOR IMMEDIATE RELEASE

DR. EDWARD HALLOWELL ANNOUNCES ADHD CERTIFICATION
PROGRAM FOR CHIROPRACTORS

The goal is achieving success for the patient by combining the Dr. Hallowell protocol with an effective chiropractic approach for people with ADHD.

Morristown, NJ – November 1, 2011 – Edward ‘Ned’ Hallowell, M.D., world renowned child and adult psychiatrist and author, announces the development of an unique on-line, on-demand certification course for chiropractors called “A Dr. Hallowell Protocol, SHINE for Doctors – Special Help Integrating Neurological Experience™.

SHINE for Doctors is a 14-video series that provides a clinically vivid wealth of information on ADHD, which chiropractors can use to gain a deep understanding of this common and fascinating trait. Approximately 8.4%, or 5.2 million children ages 3 –17, have been diagnosed with ADHD. These symptoms continue into adulthood for about 60% of children with ADHD, which translates into 4% of the US adult population, or 8 million adults. Furthermore, 50% of children and 80% of adults who have ADHD remain undiagnosed.

“People in your community, right now, are searching for a natural, effective approach to addressing ADD/ADHD”, commented Dr. Patrick Gentempo, Co-Founder of SHINE for Doctors. Too often, treatment of ADHD is presented in terms that are saturated with negative energy. This series, however, overflows with positive energy, while also presenting the facts to help the people who matter most: the patient. Dr. Gentempo concluded that “Dr. Hallowell’s Strength Based Approach, combined with chiropractic protocols, is a revolutionary solution that promises to have millions seek it out.”

Through an exclusive arrangement with Dr. Hallowell, SHINE for Doctors is available to the chiropractic profession. To learn more about the SHINE for Doctors certification course for chiropractors, visit us at www.SHINEforDoctors.com .

About Dr. Hallowell
Dr. Hallowell is the foremost leading authority in the country on ADD/ADHD and one of the most sought after expert speakers in this arena. A graduate of Harvard and Tulane Medical School, he was a member of the Harvard faculty for 11 years until retiring in 2004 to devote his professional attention to his clinical practice, lectures and writing. Dr. Hallowell has appeared on nationally televised programs like 60 Minutes, 20/20, Oprah, Dr. Oz, Dr. Phil and Good Morning America.

Creating Wellness receives Patent - Oct 2011

FOR IMMEDIAT RELEASE

WELLNESS PATENT AWARDED TO CREATING WELLNESS ALLIANCE (CWA)

CWA receives patent for their innovative Creating Wellness Assessment Process that’s only available at Creating Wellness Centers.

OCTOBER 2011, MORRISTOWN, NJ, –The Creating Wellness Alliance (CWA), an international health and wellness organization with over 300 Centers worldwide is proud to announce their newly awarded patent for their innovative Creating Wellness Assessment Process. This first-ever wellness patent was awarded and issued by the United States Patent Office.

The Creating Wellness program helps consumers reach and maintain a healthy weight and fitness level. Their Assessment Process incorporates a comprehensive Lifestyle Questionnaire and Physical assessment which measures the patient in all three dimensions of wellness – Physical, Bio-Chemical and Psychological. This assessment provides the patient a snapshot of their overall state of wellness and serves as the starting point from which they can move forward with their wellness goals. Unique to the Creating Wellness Assessment Process is the Wellness Quotient (WQ) - one number that depicts where the patient falls on the wellness continuum.

“The awarding of this patent is a culmination of a life spent working towards a wellness model that’s measurable for a consumer, commented Dr. Patrick Gentempo, Jr., Chairman and Founder of Creating Wellness Alliance. Our Creating Wellness Centers not only have the tools their clients need to be successful in their wellness journey, they now have the proof and recognition the program works,” continued Dr. Gentempo.

CWA are experts in designing wellness programs for consumers and corporations and provide a suite of wellness solutions that benefit patients with a custom approach to their wellness needs. Their wellness process offers consumers a wide array of solutions, from in-office services to 24/7 on-line programs that assist in monitoring the patients current level of wellness. In addition, these programs help consumers develop personalized fitness programs and nutritional meal plans, along with inviting them to join a number of wellness communities and forums.

Creating Wellness has centers in the USA, Canada, Europe, New Zealand and Africa.

HIDROX, used in Paradox, Wins NBT Award - May 2011

CREAGRI®'s HIDROX™ Receives the NBT Award for Outstanding Application in Health Management at Vitafoods Europe.

HIDROX™ is a main ingredient in Purpose Nutrition Paradox.

GENEVA, May 12, 2011 /PRNewswire/ -- "Clear and credible," said one judge. "An Excellent, comprehensively completed submission," said another panelist.  Overtaking many competitors, and analysts' expectations, CREAGRI®'s HIDROX™ took the Nutraceutical Industry by storm on May 11, 2011 in Geneva at the Nutraceutical Business Technology Awards ceremony.

Held in parallel to Vitafoods' Europe Expo, the NBT Award is the recognition of the decade long leading role that CREAGRI has played in the discovery, and the development, of healthy applications for polyphenol derived from the juice of organic olives.

Conferring CREAGRI the award for Outstanding Application in Health Management the international panel of judges, convened in the Swiss city by NBT Magazine, agreed that CREAGRI®'s entry into the contest not only described the creation of a powerful, natural antioxidant, but also the development of a cutting edge, patent protected technology--The Integrale™--to produce Hydroxytyrosol from olive milling waters, and to reduce the environmental impact of olive oil production.

"The winning company firmly believes that its product represents an important milestone in the development of natural products with powerful human health benefits," wrote the NBTA judges in their final decision. Strong competition for the award came from Naturex, Gumlink and Cognis.

"Today's NBT award not only recognizes the role that our company has played in the development of one of the most effective Nutraceutical ever brought to market for the management of contemporary age and stress related conditions, but it is also the validation of a line of scientific research that strives to reconnect consumers with a wellness and longevity experience deeply rooted into the ancestral history of human knowledge," affirmed Dr. Roberto Crea, founder and CEO of CREAGRI®, Inc., accepting the award on behalf of the company and its employees.

About HIDROX

HIDROX™ is CREAGRI®'s trademarked hydroxytyrosol formulation, a powerful polyphenol scientifically recognized for its anti-oxidant properties and efficacy in heart and joint health.  HIDROX™ is the only olive polyphenol formulation with GRAS certification, meaning that it has been subjected to the most comprehensive set of safety and clinical efficacy tests. HIDROX™ is also covered by the largest number of international patents for applications that include hydroxytyrosol and olive polyphenol. It is available in three forms to fulfill a variety of applications: HIDROX™ 12% Total Polyphenol (6% hydroxytyrosol) freeze dried powder, HIDROX™ 6% Total Polyphenol (3% hydroxytyrosol) powder and liquid HIDROX™ 0.5% total Polyphenol.

About Paradox

Click the bottle and learn more about Paradox.

About CREAGRI

CREAGRI® Inc., a California company, is the leading manufacturer of HIDROX®, a proprietary hydroxytyrosol-rich ingredient. Its goal is to promote health and wellness by creating superior natural products that strike a balance between nature and technology. The company develops science-based processes that are environmentally friendly and compatible with sustainable agricultural methods.

SOURCE CREAGRI, Inc.
Copyright 2011 PR Newswire. All Rights Reserved

Great Nutritional Insurance for your Health

Plenty of food,     just to many of the wrong types.

Americans are definitely getting enough food; we just don’t get the right food. Highly processed foods that taste great and are loaded with sugar, salt and fat are available for cheaper prices and in more places than healthier alternatives. That means we eat too much of the wrong types of foods. There have also been published reports showing that people who lack certain vitamins and minerals in their diets have a tendency to suffer from poorer health. According to the Harvard School of Public Health, “A daily multivitamin is a great nutrition insurance policy.”² 

Purpose Vitalizing Women’s multi’s are formulated with a comprehensive blend of vitamins and minerals that work together in the body. Purposed Nutrients™ are fermented naturally to make them more body-ready. Because they are fermented with living probiotics, Purposed Nutrients are absorbed more like food.

Purpose Nutrition utilizes a unique fermentation process. We believe that proper nutrition is fundamental to overall good health and that the most complete source of nutrition comes in whole food form. Fermentation has been an important part of healthful food preparation in the U.S. and the world for centuries. That is why we use the Purpose Nutrition fermentation process. This advanced process uses living probiotic organisms to digest nutrients into forms that are made to be easily recognizable by your body. It is a natural process that uses probiotic organisms to produce easily digestible nutrients high in nutritional value.

The natural fermentation process that began with grains and dairy led to the development of some of our most popular foods today including, beer, wine, cheese and yogurt. Fermentation is a natural part of the digestive process. In fact, a healthy body contains more probiotic microorganisms in the digestive tract than total cells in the body. Our symbiotic relationship with probiotic microorganisms are critical to good health and vitality. Purposed Nutrients can provide significantly higher benefit as compared to isolated vitamins and minerals.

For example, research at the University of Scranton showed a 238X higher antioxidant quality for Purposed selenium as compared with generic sodium selenate, a common source of selenium in multivitamins.²   Purpose Vitalizing Women’s multi’s provide select levels of the right vitamins in the right amounts for women (according to the U.S. RDA).   Purpose Vitalizing Women’s multi’s are made without binders. They are made with nutrients derived from whole foods.   Purpose Women’s Vitalizing multi’s are made with 100% vegetarian capsules for rapid release. Purpose Women’s multi’s supports vitality by utilizing a comprehensive formula of vitamins and minerals that work together in the body.

Purpose Women’s multivitamins contain mixed carotenoids, C, D, calcium, magnesium and trace minerals from the sea to support healthy bones. Copper, biotin and iron are included to support healthy blood and skin. Purpose Vitalizing Women’s multi’s contain B vitamin complex, folic acid and vitamin E to support a healthy heart. Mixed carotenoids, vitamins E & C and zinc are included to support healthy vision. Purpose Vitalizing Women’s multivitamin consists of B vitamin complex and vitamin C for life’s daily stresses. Best of all, Purposed Nutrients are easy on the stomach, and can be taken on an empty stomach. Purpose Multi’s are an excellent foundation for any nutrient program.

1. Harvard School of Public Health Nutrition Source, February 17, 2011< nutrition.about.com/.../vitaminssupplements/f/whyvitamins.htm>

2. The University of Scranton, “Comparison of Different Forms of Selenium”, Jay Udani, MD, December 27, 2002.

Southeastern Printing thanks HHAC for Economical Approach to Employee Wellness - December 2010

STUART, FL. – On December 17, 2010, an industry leader, Southeastern Printing (SEP) thanks Dr. Bruce Hansbrough and the staff at Harmony Healing Arts: A Creating Wellness Center (HHAC) for partnering with SEP to approach corporate healthcare in a manner that will change lives! During SEP’s annual employee Holiday pot-luck luncheon, Jina Caronongan, Human Resources Manager for SEP, unveiled the new and improved SEP employee wellness program featuring representatives Dr. Leo Hart and Jamie DeChambeau from HHAC, and Tommy Puhl and Kelly Schwegler, from LA Fitness, as well as SEP’s newly formed “Wellness Task Force.” HHAC and Dr. Hansbrough’s approach to assist with corporate employee health-care challenges is to “create a corporate environment where quality products and services, camaraderie, and contribution to the community are inseparable parts of the total human living experience.”

Through a partnership with HHAC, SEP will continue to deliver a company-wide wellness program which other businesses can emulate. SEP is an established leader in producing innovative, creative and cost-effective print and label packaging solutions for branded product marketing materials. The company was recently selected by the South Florida Manufacturers Association as the 2009 “Manufacturer of the Year” in their particular category. In addition, SEP received the 2010 “Benny Award” from the Printing Industries of America for “Best Brochure in the Country.” Through dynamic, visionary leadership and outstanding talent in all facets of their operation, SEP is a strategic print communications partner to the country’s largest and smallest brands. With facilities in Stuart and Palm City, Florida, as well as Naperville, Illinois, SEP is nationally recognized by their peers for producing the highest standards of award-winning work, year in and year out.

Additionally, according to Jina Caronongan from SEP, “The company actively and generously gives back to the Treasure Coast community it is so deeply rooted in by supporting such charitable causes as the Environmental Studies Center – Turtle Tracks, the Treasure Coast Wildlife Hospital, The Pine School, Martin Memorial Foundation – Robert Novins Golf for Life, Helping People Succeed, the Children’s Home Society of the Treasure Coast, and the Florida Blood Center, to name a few.” 

As a leader in corporate wellness and industrial health, Dr. Hansbrough’s team of experts are specifically trained and ready to assist companies to grapple with rising health costs and more restrictive governmental regulations. According to Hansbrough, “Global competitiveness is challenging every sector of our economy, most notably the health care sector. Employers ultimately pay the bulk of the nation’s health bill through employee benefits and payroll taxes, and this is of great concern to most economists. If we can help people to create better health, stronger families, and more fulfilling lives, then their employers are winners too."

Can Omega-3s Lower Breast Cancer Risk?

Women who took omega-3 supplements has a 32% lower incidence of breas cancer.

A new study has made a strong case that the regular use of omega-3 fish oil supplements by women may reduce the risk for breast cancer.¹ In this study, involving more than 35,000 postmenopausal women (ages 50 to 76 years), researchers at the Fred Hutchinson Cancer Research Center in Seattle found that those who said that they habitually used fish oil supplements were significantly less likely to develop invasive ductal breast cancer, the most common form of this cancer.  Led by Emily White, Ph.D., the researchers asked women who did not have a history of breast cancer to complete a 24-page questionnaire about their use of nonvitamin, nonmineral “specialty” supplements in the study which was aptly named the Vitamins and Lifestyle (VITAL) cohort study. The woman, who frequently took omega-3 supplements over a span of six years, had a 32% lower incidence of breast cancer.

Despite known and suspected risk factors for breast cancer in some of the women, the lower risk was still seen. These risk factors included older age, obesity, heavy drinking, and sedentary lifestyle. Unfortunately, the study was limited because it was an “observational” study, one in which researchers examine the relationship between “exposure,” such as supplement use, and a disease risk. The problem with studies of this type, according to Dr. White, is that, “It cannot show cause-and-effect.” Nevertheless, Dr. White said that it is too soon to recommend that postmenopausal women start taking fish oil for the sake of lowering breast cancer risk. Haven’t we heard this before?

Should Women Wait?

Dr. White also announced that recommendations may follow new evidence from clinical trials that are forthcoming, and specifically a Harvard University trial, just now underway, that will examine the effects of fish oil and vitamin supplements on the risks for cancer, heart disease, and stroke in older men and women. In that study, researchers aim to enroll 20,000 U.S. adults, who will be randomly assigned to take one or both supplements, or placebo pills to serve as a comparison. This type of random double-blind placebo-controlled study is considered the “gold standard” for demonstrating cause-and-effect. But how long will women need to wait, and what will happen during the wait?

Millions of Preventable Deaths

Fish oil, a rich source of omega-3 fatty acids, has been found to be beneficial for heart health, and much more. A number of clinical trials have shown that fish oil may help lower triglycerides (a type of blood fat), high blood pressure and the risk of heart attack in people with established heart disease. High fish consumption has also been linked to a lower risk of developing heart disease. In addition, fish oil is very safe.

Consequently, some experts recommend that adults should consume fish at least twice a week, preferably fish like salmon, mackerel, and trout that contain high omega-3 levels. However, in the White study, 83% of fish oil users took fish oil ≥ 4 times a week, 60% of whom were daily users.  The researchers concluded that the participants who used fish oil supplements probably consumed the equivalent of 33–77% of a serving of high omega-3 containing fish each day that the supplement was used. That’s higher than the general recommendation.

According to another recent study, published by the Harvard School of Public Health, the top six preventable risks in the average American lifestyle alone kill more than one million people each year, with omega-3 deficiency now the sixth most significant factor.² Out of the one million preventable deaths (which may be as high as 1.6 million), nearly 100,000 deaths are attributed to health problems related to this insufficient dietary intake, making it a more significant issue than an excessive consumption of trans-fats. That’s amazing! So if we have to wait until the results of the “gold standard” study come in, perhaps 6–8 years, 600,000 to 800,000 individuals will die of preventable deaths. Is there any evidence that the regular use of fish oil supplements is dangerous? Not really. Fish oil is generally considered safe when taken as directed, although it can have side effects, such as stomach upset, heartburn and, at higher doses, bleeding. But when weighed against the upshot of cancer prevention, these are contextually minor.

Fish Oil Lowers Breast Cancer Risk by One-Third

Back to the White et al study, after gathering baseline data, the researchers followed the women for an average of six years to record any diagnoses of breast cancer. Over that period, 880 women were diagnosed with the disease, and of that number, 5 percent had reported regularly using fish oil when the study began. Among women who remained cancer-free, 8 percent had been current fish oil users at the outset. Thus, fish oil use at the start of the study was related to a one-third lower risk of developing breast cancer compared with non-use. These calculations were deconfounded for age, weight, diet and exercise habits, and family history of breast cancer.

Fish oil is known to have anti-inflammatory effects, and chronic inflammation in the body is thought to play a role in the growth and spread of cancer cells. Thus, it is biologically feasible that fish oil could have had a causal effect. In a written statement, noted researcher, Dr. Edward Giovannucci, of the Harvard School of Public Health in Boston, comments, “It is very rare that a single study should be used to make a broad recommendation. … Over a period of time, as the studies confirm each other, we can start to make recommendations.” I’m willing to bet that Dr. Giovanucci takes omega-3 supplements. In fact, when earlier large-scale studies on vitamin E were first published finding positive correlations, despite the usual cautionary notices to wait until there was complete certainty, several Harvard researchers involved in these studies admitted that they were already taking vitamin E supplements. Amazing!

Omega-3s, the Swiss Army Knife of Nutrients

Let’s examine some of the many benefits attributed to omega-3 fish oil.

All-cause mortality: Researchers from Tufts-New England Medical Center report increased consumption of omega-3s from fish or supplements (EPA & DHA, but not ALA) reduces the rates of all-cause mortality, cardiac and sudden death, and possibly stroke.³

Alzheimer’s disease: More than a dozen studies have reported that reduced levels or intake of omega-3s or fish consumption is associated with increased risk for age-related cognitive decline or dementia such as Alzheimer’s disease, reports the Department of Medicine at the University of California, Los Angeles.⁴ Results also suggest that DHA may be more effective if it is begun early or used in conjunction with antioxidants.

Arthritis: Fish oil has been shown to slow the development of arthritis in an animal model and to reduce disease severity. Clinical trials have demonstrated rheumatoid arthritis patients who take fish oil have less pain, less morning stiffness and require fewer non-steroidal anti-inflammatory drugs.⁵

Arrhythmia prevention: Numerous epidemiological studies, case-control series, and randomized trials have demonstrated the ability of fish oil to reduce major cardiovascular events, particularly sudden cardiac death and all-cause mortality. Any patient with documented coronary heart disease and those with risk factors for sudden cardiac death—such as left ventricular dysfunction, left ventricular hypertrophy, prior myocardial infarction, or high-grade ventricular dysrhythmias—should consider fish oil supplementation.⁶

Atopic eczema: DHA intake has been associated with a reduced prevalence of atopic eczema in pregnant Japanese females.⁷

Blood pressures and resting heart rates: Higher levels of DHA in circulating blood biomarkers have been connected with reduced risks for the progression of coronary atherosclerosis and lowered risk from sudden cardiac death. Controlled clinical trials have also indicated the potential for DHA supplementation to have moderate beneficial effects on other cardiovascular disease risk factors, including blood pressures and resting heart rates.⁸

Breast cancer: In a case controlled study, the National Cancer Center Hospital found that a high intake of fatty fish was associated with a reduced risk for breast cancer in both pre- and postmenopausal women.⁹

Cardiovascular disease: A study from the Institute of Endocrinology and Nutrition, at the University of Valladolid, Spain, suggests that a high dietary intake of omega-3s may offer a protective effect against atherosclerotic disease (hardening of the arteries) and reduce serum triglycerides levels. In this study, omega-3 supplementation improved lipid profile and inflammatory markers in patients with diabetes mellitus type 2 and hypertriglyceridemia.¹⁰

Chronic depressive symptoms: From a recent study in Nutrition, data suggest that a higher dietary intake of long-chain omega-3 polyunsaturated acids may lead to a decreased risk of depressive disorders. Findings suggest that dietary intakes of fish and long-chain omega-3 fatty acids help prevent chronic depressive symptoms in women.¹¹

Cognitive decline slow-down: Fish consumption may be associated with slower cognitive decline with age, reports the Rush Institute for Healthy Aging, Rush University Medical Center in Chicago.¹²

Cognitive function impairment: Researchers from the Netherlands report that fatty fish and marine omega-3 consumption was associated with a reduced risk of impaired cognitive function in a middle-aged population, while an intake of cholesterol and saturated fat was associated with an increased risk of impaired cognitive function.¹³

Depression: Depressive disorders with idiopathic (unexplained) symptoms are the most common form of depression. Deficiency of the omega-3 fatty acid DHA is associated with dysfunctions of neuronal membrane stability and transmission of serotonin, norepinephrine and dopamine, which might connect to mood and cognitive dysfunction in depression.¹⁴

Fatal coronary heart disease and sudden cardiac death: Large observational studies, randomized clinical trials, and experimental studies have evaluated the effects of fish and omega-3 fatty acid consumption on fatal coronary heart disease (CHD) and sudden cardiac death (SCD). The Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School concludes that because more than one-half of all CHD deaths and two-thirds of SCD occur among individuals without recognized heart disease, modest consumption of fish or fish oil—together with smoking cessation and regular moderate physical activity—should be among the first-line treatments for prevention of CHD death and SCD.¹⁵

General health: The DHA component of omega-3s has been found to protect against heart disease and might be beneficial in rheumatoid arthritis, inflammatory bowel diseases, childhood learning and behavior, and adult psychiatric and neurodegenerative illnesses. DHA has an important structural role in the eye and brain, and its supply early in life is known to be of vital importance. Because of these recognized health improvements brought about by DHA, recommendations have been made to increase its intake, especially because most individuals living in Western countries eat low amounts of foods containing DHA.¹⁶

General health: A comprehensive review of omega-3 finds that omega-3 fatty acids are essential in human health and disease and reduce death and poor health from heart problems. Dietary supplementation may also benefit patients with blood lipid abnormalities, atherosclerosis, hypertension, diabetes mellitus, metabolic syndrome (pre-diabetes), obesity, inflammatory diseases, neurological/neuropsychiatric disorders and eye diseases. Consumption of omega-3s during pregnancy reduces the risk of premature birth and improves intellectual development of the fetus.¹⁷

Heart attack: Higher blood levels of omega-3s were associated with a decreased risk of a heart attack (myocardial infarction.)¹⁸

Heart failure sudden death: UK researchers report that dietary omega-3s reduce the risk of sudden death. These fatty acids also have potent anti-inflammatory effects, and may prevent clots and heart vessel blockage. The use of omega-3s should be considered as part of a comprehensive secondary prevention strategy post-myocardial infarction.¹⁹

Hypertension: Omega-3 polyunsaturated fatty acids from fish and fish oils appear to protect against coronary heart disease; their dietary intake is in fact inversely associated with cardiovascular disease morbidity/mortality in population studies. Recent evidence suggests that at least a part of this protective effect is mediated by a relatively small but significant decrease in blood pressure (BP) level.²⁰

Inflammation: In a report from the University of Oklahoma, researchers described how dietary supplementation of omega-3 fatty acids generates potent mediators that control inflammation that is a key factor leading to colon cancer.²¹

Insulin resistance: Omega-3s have shown clinical significance in the prevention and reversal of insulin resistance reports researchers from University of California, Davis.²²

Joint pain: Omega-3 polyunsaturated fatty acids have been used to treat joint pain associated with several inflammatory conditions. The results, published in the journal Pain suggest that omega-3s are an attractive adjunctive treatment for joint pain associated with rheumatoid arthritis, inflammatory bowel disease, and dysmenorrhea.²³

Kidney disease: A high dietary intake of omega-3s reduces diabetic renal (kidney) disease, according to researchers at the University of Mississippi Medical Center.²⁴

Macular degeneration: A study from the Archives of Ophthalmology reports a diet low in trans-unsaturated fat and rich in omega-3 fatty acids and olive oil may reduce the risk of age-related macular degeneration (AMD).²⁵

Macular degeneration: A study from the Centre for Vision Research in Australia provides evidence of protection against early AMD from regularly eating fish, greater consumption of omega-3 polyunsaturated fatty acids, and low intakes of foods rich in linoleic acid.²⁶

Macular degeneration: A large study from the National Eye Institute reports that dietary lipid intake is a modifiable factor that may influence the likelihood of developing sight-threatening forms of AMD. The findings suggest that dietary omega-3 long-chain polyunsaturated fatty acid intake is associated with a decreased risk of progression of macular degeneration.²⁷

Metabolic syndrome: Omega-3 consumption significantly benefits metabolic syndrome (pre-diabetes) and type 2 diabetes primarily with their impact on blood pressure, glucose control, and inflammation. Omega-3s reduce conversion of metabolic syndrome to type 2 diabetes and reduce death rates due to metabolic syndrome and type 2 diabetes.²⁸

Metastatic cancer: Eating fish more than three times per week was associated with a reduced risk of prostate cancer, and the strongest association was for metastatic cancer, compared with infrequent consumption (less than twice per month). Each additional daily intake of 0.5 g of marine fatty acid from food was associated with a 24% decreased risk of metastatic cancer.²⁹

Neuropsychiatric disorders: Epidemiological research indicates that omega-3s may modify the risk for certain neuropsychiatric disorders. Supporting these, the researhers note that decreased blood levels of omega-3 fatty acids have been associated with several neuropsychiatric conditions, including attention deficit hyperactivity disorder, Alzheimer’s disease, schizophrenia, and depression.³⁰

Prostate protection: Researchers at the University of California, San Francisco found that dietary DHA appears protective against aggressive prostate cancer.³¹

Prostate cancer risk reduction: Omega-3s inhibit prostate tumor growth and higher intakes may reduce the risk of total and advanced prostate cancer, reports the National Cancer Institute, National Institutes of Health.³²

Psoriasis: Psoriasis is an inherited inflammatory skin disease influenced by environmental factors. High intake of omega-3s show beneficial effects, along with fasting, low-calorie and vegetarian diets.³³

Rheumatoid arthritis: A recent report finds that fish oil rich in omega-3 fatty acids, especially EPA and DHA, protects against inflammation-induced bone loss in chronic inflammatory diseases like rheumatoid arthritis, periodontitis, and osteoporosis.³⁴

Stroke: From JAMA, higher consumption of fish and omega-3 polyunsaturated fatty acids is associated with a reduced risk of thrombotic infarction, primarily among women who do not take aspirin regularly, but is not related to risk of hemorrhagic stroke.³⁵

Stroke: In the latest and largest stroke study, the Nurses Health Study, a significant decrease in the risk of thrombotic stroke was observed among women who ate fish at least two times per week compared with women who ate fish less than once per month, after adjustment for age, smoking, and other cardiovascular risk factors.³⁶ These data support the hypothesis that consumption of fish several times per week reduces the risk of thrombotic stroke, but does not increase the risk of hemorrhagic stroke.

Sudden cardiac death: During the past 25 years, the cardiovascular effects of omega-3s have been the subject of increasing investigation. In the late 1970s, epidemiological studies revealed that Greenland Inuits had substantially fewer heart attacks compared with Western control subjects. These observations generated more than 4,500 studies to explore this and other effects of omega-3 fatty acids on human metabolism and health. From epidemiology to cell culture and animal studies to randomized controlled trials, the cardioprotective effects of omega-3 fatty acids are becoming widely recognized. A recent study of 11,324 patients showed a 45% decrease in risk of sudden cardiac death and a 20% reduction in all-cause mortality in the group taking 850 mg/day of omega-3 fatty acids.³⁷

Which is Better: Eating Fish or Taking Fish Oil Supplements?

The American Journal of Cardiology reported that large amounts of fish consumption may result in adverse experiences due to the potential presence of environmental toxins such as mercury, polychlorinated biphenyls, dioxins, and other contaminants. The risks of exposure to environmental toxins and hypervitaminosis with fish consumption are substantially reduced through purification processes used to develop selected concentrated fish oil supplements.³⁸

In another study, the consumption of equal amounts of EPA and DHA from oily fish consumed on a weekly basis or from fish-oil capsules on a daily basis is equally effective at enriching blood lipids with omega-3s, reports Saint Luke’s Mid America Heart Institute, Kansas City, Missouri.³⁹

_____________________________________

The Optimal serving size of omega-3s is about
4 grams/day for most individuals.
_____________________________________

How Much to Take?

Consolidating dose/benefit relationships has enabled us to conclude that the optimal serving size of omega-3s is about 4 grams/day for most individuals, especially if they are predisposed to any of the above conditions. Once again, while omega-3s are quite safe, it is always wise to work with a nutritionally-conscious physician to insure against the possibility that the recommended levels may not be right for you. By the way, the American public agrees with the importance of taking fish oil supplements.  They are now the most popular of all individual supplements taken for general health and specific conditions.

Learn more about Pupose Nutrition Cardio 0-3 fish oil.

*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

References

1. Brasky TM, Lampe JW, Potter JD, Patterson RE, White E. Specialty Supplements and Breast Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomarkers Prev 2010 Jul;19(7):1696-708.
2. Danaei et al. The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors. PLoS Medicine 2009 April; 6(4):e1000058
3. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J., Omega-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006 Jul;84(1):5-17.
4. Omega-3 fatty acids and dementia. Cole GM, Ma QL, Frautschy SA. Prostaglandins Leukot Essent Fatty Acids 2009 Aug-Sep;81(2-3):213-21.
5. Calder PC. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on ‘Nutrition and autoimmune disease’ PUFA, inflammatory processes and rheumatoid arthritis. Proc Nutr Soc 2008 Nov;67(4):4009-18.
6. Anand RG, Alkadri M, Lavie CJ, Milani RV. The role of fish oil in arrhythmia prevention. J Cardiopulm Rehabil Prev 2008 Mar-Apr;28(2):92-8.
7. Miyake Y, Sasaki S, Tanaka K, Ohya Y, Matsunaga I, Yoshida T, Hirota Y, Oda H. Relationship between dietary fat and fish intake and the prevalence of atopic eczema in pregnant Japanese females: baseline data from the Osaka Maternal and Child Health Study. Asia Pac J Clin Nutr 2008;17(4):612-9.
8. Holub BJ. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors. Prostaglandins Leukot Essent Fatty Acids 2009 Aug-Sep;81(2-3):199-204.
9. Kim J, Lim SY, Shin A, Sung MK, Ro J, Kang HS, Lee KS, Kim SW, Lee ES. Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study. BMC Cancer 2009 Jun 30;9(1):216.
10. De Luis DA, Conde R, Aller R, Izaola O, Gonzalez Sagrado M, Perez Castrillon JL, Duenas A, Romero E. Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study. Eur Rev Med Parmacol Sci 2009 Jan-Feb;13(1):51-5.
11. Colangelo LA, He K, Whooley MA, Daiglus ML, Liu K. Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition 2009 Oct;25(10):1011-9.
12. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. Fish consumption and cognitive decline with age in a large community study. Arch Neurol 2005 Dec;62(12):1849-53
13. Kalmijn S, van Boxtel MP, Ocké M, Verschuren WM, Kromhout D, Launer LJ.Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004 Jan 27;62(2):275-80.
14. Su KP. Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a “mind-body interface”? Neurosignals 2009;17(2):144-52.
15. Mozaffarian D.Fish and omega-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am J Clin Nutr 2008 Jun;87(6):1991S-6S.
16. Calder PC, Yaqoob P. Omega-3 polyunsaturated fatty acids and human health outcomes. Biofactors 2009 May-Jun;35(3):266-72.
17. Yashodhara BM, Umakanth S, Pappachan JM, Bhat SK, Kamath R, Choo BH. Omega-3 fatty acids: a comprehensive review of their role in health and disease. Postgrad Med J 2009 Feb;85(1000):84-90.
18. Park Y, Lim J, Lee J, Kim SG. Erythrocyte fatty acid profiles can predict acute non-fatal myocardial infarction. Br J Nutr 2009 Jun 9:1-7
19. Lee KW, Lip GY. The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. QJM 2003 Jul;96(7):465-80.
20. Cicero AF, Ertek S, Borghi C. Omega-3 polyunsaturated Fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol 2009 Jul;7(3):330-7.
21. Janakiram NB, Rao CV. Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer. Curr Mol Med 2009 Jul;9(5):565-79.
22. Fedor D, Kelley DS. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 2009 Mar;12(2):138-46.
23. Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007 May;129(1-2):210-23.
24. Garman JH, Mulroney S, Mnigrasso M, Flynn E, Maric C. Omega-3 fatty acid rich diet prevents diabetic renal disease. Am J Physiol Renal Physiol 2009 Feb;296(2):F306-16.
25. Chong EW, Robman LD, Simpson JA, Hodge AM, Aung KZ, Dolphin TK, English Dr, Giles GG, Guymer RH. Fat consumption and its association with age-related macular degeneration. Arch Ophthalmol 2009 May;127(5):674-80.
26. Tan JS, Wang JJ, Flood V, Mitchell P. Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol 2009 May;127(5):656-65.
27. SanGiovanni JP, Chew EY, Agron E, Clemons TE, Ferris FL 3rd, Gensler G, Lindblad AS, Milton RC, Seddon JM, Klein R, Sperduto RD. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23.; Age-Related Eye Disease Study Research Group. Arch Ophthalmol 2008 Sep;126(9):1274-9.
28. Barre DE. The role of consumption of alpha-linolenic, eicosapentaenoic and docosahexaenoic acids in human metabolic syndrome and type 2 diabetes—a mini-review. J Oleo Sci 2007;56(7):319-25.
29. Augustsson K, Michaud DS, Rimm EB, Leitzmann MF, Stampfer MJ, Willett WC, Giovannucci E. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev 2003 Jan;12(1):64-7.
30. Young G, Conquer J. Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev 2005 Jan-Feb;45(1):1-28.
31. Fradet V, Cheng I, Casey G, Witte JS. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res 2009 Apr 1;15(7):2559-66.
32. Leitzmann MF, Stampfer MJ, Michaud DS, Augustsson K, Colditz GC, Willett WC, Giovannucci EL. Dietary intake of omega-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr 2004 Jul;80(1):204-16.
33. Araujo ML, Burgos MG, Moura IS. Nutritional influences in psoriasis. An Bras Dermatol 2009 Jan-Feb;84(1):90-2.
34. Rahman MM, Bhattacharya A, Fernandes G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol 2008 Jan;214(1):201-9.
35. Iso H, Rexrode KM, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Hennekens CH, Willett WC. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001 Jan 17;285(3):304-12.
36. Skerrett PJ, Hennekens CH. Consumption of fish and fish oils and decreased risk of stroke. Prev Cardiol 2003 Winter;6(1):38-41.
37. O’Keefe JH Jr, Harris WS. From Inuit to implementation: omega-3 fatty acids come of age. Mayo Clin Proc 2000 Jun;75(6):607-14.
38. Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol 2007 Mar 19;99(6A):35C-43C.
39. Harris WS, Pottala JV, Sands SA, Jones PG. Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids. Am J Clin Nutr 2007 Dec;86(6):1621-5.
    ____________________________________________________
    By Will Block, publisher and editorial director of Life Enhancement magazine.

Find A Center | Member Log-In | Community| Wellness 4 You| Wellness in the Workplace | Become a Center | CW in the News | Terms of use | Careers | Contact Us